| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-14 08:55 Tx date 2023-08-14 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Indirect Ownership)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
-$100,000 vol |
$0 | |
| Filed 2025-09-24 14:28 Tx date 2025-09-13 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-50,000
-125,000 vol $0.40 each |
0 | |
| Filed 2025-03-04 15:48 Tx date 2022-09-13 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+250,000 vol $0.40 each |
250,000 | |
| Filed 2025-03-04 12:42 Tx date 2024-12-20 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$144,000
+160,000 vol $0.90 each |
488,169 | |
| Filed 2024-12-20 17:07 Tx date 2024-12-20 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$144,000
+160,000 vol $0.90 each |
||
| Filed 2022-09-14 09:01 Tx date 2022-09-13 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+250,000 vol $0.40 each |
||
| Filed 2025-02-18 09:19 Tx date 2025-02-10 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,237,891
+2,832,774 vol $0.79 each |
6,195,691 | |
| Filed 2024-12-20 17:07 Tx date 2024-12-20 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$144,000
+160,000 vol $0.90 each |
3,648,220 | |
| Filed 2024-05-17 11:04 Tx date 2024-05-16 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,280
+24,000 vol $0.47 each |
3,488,220 | |
| Filed 2024-05-17 11:04 Tx date 2024-05-16 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,325
+5,000 vol $0.465 each |
3,464,220 | |
| Filed 2024-05-02 15:13 Tx date 2024-05-02 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,421
+47,000 vol $0.4345 each |
3,459,220 | |
| Filed 2023-09-07 16:20 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,991
+18,500 vol $0.486 each |
328,169 | |
| Filed 2023-09-07 16:20 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,120
+6,500 vol $0.48 each |
309,669 | |
| Filed 2023-09-07 16:19 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,485
+25,000 vol $0.4594 each |
303,169 | |
| Filed 2023-09-07 16:19 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,252
+25,000 vol $0.4501 each |
278,169 | |
| Filed 2023-09-07 16:18 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,625
+25,000 vol $0.425 each |
253,169 | |
| Filed 2023-06-05 10:03 Tx date 2023-06-01 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,108,517 vol |
3,362,917 | |
| Filed 2023-05-19 15:25 Tx date 2023-05-17 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+200,000 vol $0.50 each |
228,169 | |
| Filed 2023-03-28 10:25 Tx date 2023-03-24 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Debentures
16 - Acquisition or disposition under a prospectus exemption
|
+$100,000 vol |
$100,000 | |
| Filed 2023-03-28 10:20 Tx date 2021-08-13 |
$MSCL
Satellos Bioscience Inc. |
Gleeson, Francis (Frank) Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 6857990 Canada Inc. (Control or Direction)
|
Debentures
00 - Opening Balance-Initial SEDI Report
|